Helminth parasites are endemic in many developing countries. The overall burden of disease due to these pathogens is high, with approximately 300 million infected people suffering from severe morbidity. Here we will focus on M2 macrophages, which play crucial host protective roles in helminth infections. Macrophages can adopt different activation states depending on context. Interferon- in combination with TLR agonists promotes M1 (or classical) activation, whereas the cytokines IL-4 and IL-13 promote M2 (or alternative) activation. Differential functions in M1 and M2 macrophages are supported by distinct core metabolisms, with M1 cells committing to aerobic glycolysis, and M2 macrophages utilizing fatty acid oxidation (FAO) and mitochondrial oxidative phosphorylation. Indeed, FAO has been shown to be necessary for M2 activation. This realization has focused our attention on fatty acid metabolism, which since it is essential for M2 activation must, by definition, be an essential face of protection against helminth infections. Fatty acids for FAO are derived from the lysosomal lipolysis of triacylglycerols, which are sourced either from the exterior or through endogenous synthesis of fatty acids. Despite the fact that it is clear that FAO is essential for M2 activation the underlying reasons for the importance of this type of metabolism for M2 activation are unclear. We hypothesize that FAO serves as an efficient source of citrate for export into the cytosol where it can be used for processes that are critical for M2 activation such as synthesis of fatty acids for FAO and to act as ligands for PPARs, and the production of acetate for the acetylation of histones to permit the expression of M2 genes. In addition to their role in immunity to helminths, M2 macrophages play roles in wound healing, and in whole body metabolic homeostasis. Remarkably, helminth infection has been reported to be capable of mitigating the metabolic consequences of a high fat diet. We hypothesize that strong type 2 immunity induced by helminth infection is able to maintain metabolic homeostasis by broadly supporting M2 activation in tissues distal to the site of infection and will explore this in our third aim.
The specific aims of this project are: 1. To establish whether fatty acid synthesis is necessary for M2 activation. 2. To assess the metabolic control of histone acetylation in M2 activation. 3. To determine whether type 2 immunity in helminth infection modulates metabolic homeostasis by broadly supporting M2 activation. We will use genetic loss of function and chemical inhibitor approaches to target key genes encoding enzymes, transcription factors and receptors involved in lipid metabolism to explore M2 activation in reductionist systems and during infection with helminth parasites. We will examine the outcome of alterations in lipid metabolism on infection with these organisms, and will examine the underlying basis for beneficial effects of helminth infections on metabolic disorders associated with obesity.

Public Health Relevance

Helminth infections are Neglected Tropical Diseases caused by with parasitic platyhelminths and nematodes. They continue to represent a cause of severe morbidity in millions of people, and yet paradoxically under some circumstances can also confer protection against certain prevalent diseases of westernized societies, such as obesity related disorders. Our research is directed towards understanding basic metabolic mechanisms that may underpin both protection against helminth infections and mitigation of obesity related disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI110481-04
Application #
9395873
Study Section
Immunity and Host Defense (IHD)
Program Officer
Wali, Tonu M
Project Start
2015-01-13
Project End
2019-12-31
Budget Start
2018-01-01
Budget End
2018-12-31
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Institute Fur Immunbiologie/Epigenetik
Department
Type
DUNS #
331472555
City
Freiburg
State
Country
Germany
Zip Code
79108
Klein Geltink, Ramon I; O'Sullivan, David; Corrado, Mauro et al. (2017) Mitochondrial Priming by CD28. Cell 171:385-397.e11
Jones, Russell G; Pearce, Edward J (2017) MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells. Immunity 46:730-742
Buck, Michael D; O'Sullivan, David; Klein Geltink, Ramon I et al. (2016) Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming. Cell 166:63-76
Huang, Stanley Ching-Cheng; Smith, Amber M; Everts, Bart et al. (2016) Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation. Immunity 45:817-830
Wu, Duojiao; Sanin, David E; Everts, Bart et al. (2016) Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function. Immunity 44:1325-36
Pearce, Edward J; Huang, Stanley Ching-Cheng (2015) The metabolic control of schistosome egg production. Cell Microbiol 17:796-801